Zentalis Pharmaceuticals Inks Deal at Empire State Realty Trust’s 1359 Broadway
By Celia Young April 21, 2021 4:23 pm
reprints
Zentalis Pharmaceuticals is opening a new corporate office space at Empire State Realty Trust’s 1359 Broadway.
The clinical-stage biopharmaceutical company last month signed an 11-year lease for 31,362 square feet of space in the Garment District building, between West 36th and West 37th streets, according to the landlord. Asking rent was $73 per square foot. The company will move into the new space later this year.
Zentalis will use its new corporate office for its work on discovering and developing therapies that target the biological pathways of cancers. The company was attracted to this new location because of its sustainable practices and state-of-the-art HVAC systems, Dr. Anthony Sun, chairman and CEO of Zentalis, said in a press release.
“We are thrilled our new corporate office space will provide our growing team with a healthy and productive work environment to help bring innovative cancer treatments to patients,” Sun said. “As we continue to expand our Company’s presence in New York City, minimizing the environmental impacts of our business remains a key priority. We look forward to moving into one of ESRT’s buildings later this year, as the space is dedicated to instilling energy efficiency and sustainable practices.”
Other tenants in the 22-story office building include the New York State Energy Research and Development Authority, SLCE Architects, Sisense, Wolfgang’s Steakhouse and Fresh & Co.
Justin Royce and Omar Sozkesen of Cushman & Wakefield represented Zentalis in the lease negotiations. Keith Cody of ESRT handled it in-house for the landlord.
“We are thrilled to have helped Zentalis grow its presence in Manhattan,” said Royce. “The tenant’s commitment to expansion is proof of its dedication to New York City. Zentalis’ sustainability goals and focus on a healthy and productive work environment aligned well with the landlord’s energy-efficient practices.”
